111

OPTIPHARM. CO., LTD

No trades
See on Supercharts
Market capitalization
‪101.08 B‬KRW
‪−2.44 B‬KRW
‪17.37 B‬KRW
‪8.67 M‬
Beta (1Y)
0.56

About OPTIPHARM. CO., LTD

CEO
Hyun-Il Kim
Headquarters
Cheongju
Employees (FY)
77
Founded
2000
ISIN
KR7153710009
FIGI
BBG00LQ019K1
Optipharm Co., Ltd. is engaged in the manufacturing and wholesaling of pharmaceutical products. It offers pharmaceutical preparations. The company was founded on July 27, 2000 and is headquartered in Cheongju-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 153710 is 6860 KRW — it has increased by 0.15% in the past 24 hours. Watch OPTIPHARM. CO., LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange OPTIPHARM. CO., LTD stocks are traded under the ticker 153710.
153710 stock has risen by 2.24% compared to the previous week, the month change is a 5.54% rise, over the last year OPTIPHARM. CO., LTD has showed a 21.87% decrease.
153710 reached its all-time high on Aug 21, 2020 with the price of 31150 KRW, and its all-time low was 4700 KRW and was reached on Mar 19, 2020. View more price dynamics on 153710 chart.
See other stocks reaching their highest and lowest prices.
153710 stock is 1.33% volatile and has beta coefficient of 0.56. Track OPTIPHARM. CO., LTD stock price on the chart and check out the list of the most volatile stocks — is OPTIPHARM. CO., LTD there?
Today OPTIPHARM. CO., LTD has the market capitalization of ‪100.49 B‬, it has increased by 0.30% over the last week.
Yes, you can track OPTIPHARM. CO., LTD financials in yearly and quarterly reports right on TradingView.
153710 net income for the last quarter is ‪−141.41 M‬ KRW, while the quarter before that showed ‪−710.46 M‬ KRW of net income which accounts for 80.10% change. Track more OPTIPHARM. CO., LTD financial stats to get the full picture.
No, 153710 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 17, 2024, the company has 77.00 employees. See our rating of the largest employees — is OPTIPHARM. CO., LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OPTIPHARM. CO., LTD EBITDA is ‪−1.20 B‬ KRW, and current EBITDA margin is −6.90%. See more stats in OPTIPHARM. CO., LTD financial statements.
Like other stocks, 153710 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OPTIPHARM. CO., LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OPTIPHARM. CO., LTD technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OPTIPHARM. CO., LTD stock shows the sell signal. See more of OPTIPHARM. CO., LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.